Find clinical trials for Lung Cancer in St Louis, MO
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lung Cancer trials near St Louis, MO, USA:
This is a study of the efficacy, pharmacokinetics, and safety of DS-1062a in participants with advanced or metastatic non-small cell lung ca...
Phase 2
Saint Louis, Missouri, United States and 83 other locations
Study of MGY825 single agent in adult patients with advanced non-small cell lung cancer....
Phase 1
Saint Louis, Missouri, United States and 13 other locations
(CT-STAR) to central and ultra-central early-stage non-small cell lung cancers on grade 3 or greater toxicity. Online adaptive radi...
Saint Louis, Missouri, United States
Chimeric Degradation Activation Compound (CDAC). BG-60366 is designed to degrade mutant EGFR, which is a common cause for Non-Small Cell Lung...
Phase 1
Saint Louis, Missouri, United States and 38 other locations
This is a Phase II, multi-site, open-label, parallel group study in participants with untreated extended-stage small-cell lung cancer...
Phase 2
Fenton, Missouri, United States and 64 other locations
This study is being done to determine the efficacy and safety of cofetuzumab pelidotin in the PTK7-expressing, recurrent non-small cell lung ...
Phase 1
Saint Louis, Missouri, United States and 25 other locations
results observed in participants with Extensive-stage Small Cell Lung Cancer (ES-SCLC) who received at least 1 prior line of platin...
Phase 2
Saint Louis, Missouri, United States and 55 other locations
The goal of this platform clinical trial is to test how well novel treatment combinations work in participants with lung cancer. Su ...
Phase 2
Saint Louis, Missouri, United States and 86 other locations
in patients with BRAFV600E-mutant metastatic non-small cell lung cancer (NSCLC). Patients who are either treatment-naïve, OR who ha...
Phase 2
Saint Louis, Missouri, United States and 157 other locations
In this study, patients with small cell or non-small cell lung cancer will receive ADI-PEG 20, gemcitabine, and docetaxel after dem...
Phase 1, Phase 2
Saint Louis, Missouri, United States and 1 other location
Clinical trials
Research sites
Resources
Legal